The Journal of Organic Chemistry
Note
(Potentiometric Automatic Titrator 794 Basic Titrino, Metrohm) with
a Combined LL pH glass electrode (Metrohm) have been described in
ref 29. All of the test solutions (50 mL) were maintained under a
nitrogen atmosphere. The potentiometric pH titrations were per-
formed with I = 0.1 (NaNO3) at 25.0 °C (0.1 M aqueous NaOH was
used as the base). The deprotonation constants were determined using
and 8-azidooct-1-ylamine32 in a similar manner as that for 13. The
crude product was purified by column chromatography on silica gel
(CHCl3/MeOH = 12:1) to give 14 (23 mg, 30% yield). H NMR
1
(400 MHz, methanol-d4/TMS) δ 7.94 (brs, 1H) 4.49 (dd, J = 7.8, 4.5
Hz, 1H), 4.30 (dd, J = 7.8, 4.5 Hz, 1H), 3.29−3.13 (m, 7H), 2.92 (dd,
J = 12.8, 5.0 Hz, 1H), 2.70 (d, J = 12.8 Hz, 1H), 2.19 (t, J = 7.1 Hz,
2H), 2.17 (t, J = 7.6 Hz, 2H), 1.76−1.34 (m, 24H) ppm; 13C NMR
(100 MHz, methanol-d4) δ 176.02, 175.97, 166.13, 63.39, 61.63, 57.02,
52.45, 41.05, 40.34, 40.21, 37.01, 36.82, 30.39, 30.27, 26.76, 30.20,
30.14, 29.90, 29.80, 29.50, 27.90, 27.77, 27.57, 26.94 ppm; HRMS
(FAB) calcd for C24H44N7O3S [M + H]+ 510.3221; found 510.3222.
Ligand Catalyst (7b). This compound was synthesized from 14
and N,N-dimethylpropargylamine in a similar manner as that for 7a.
The crude product was purified by preparative thin layer column
chromatography (CHCl3/MeOH = 10:1 containing 0.5% Et3N) to
give 7b (18 mg, 73% yield). 1H NMR (400 MHz, methanol-d4/TMS)
δ 7.97 (s, 1H) 4.48 (dd, J = 7.8, 4.5 Hz, 1H), 4.41 (t, J = 7.1 Hz, 2H),
4.30 (dd, J = 7.8, 4.5 Hz, 1H), 3.81 (s, 2H), 3.21 (dd, J = 9.7, 5.0 Hz,
1H), 3.15 (t, J = 7.8 Hz, 2H), 3.14 (t, J = 7.8 Hz, 2H), 2.92 (dd, J =
12.8, 5.0 Hz, 1H), 2.70 (d, J = 12.8 Hz, 1H), 2.40 (s, 6H), 2.18 (t, J =
7.8 Hz, 2H), 2.17 (t, J = 7.8 Hz, 2H), 1.77−1.26 (m, 24H) ppm; 13C
NMR (100 MHz, methanol-d4) δ 175.97, 175.94, 166.10, 142.73,
125.92, 63.37, 61.61, 57.02, 53.82, 51.39, 44.36, 41.06, 40.30, 40.19,
36.99, 36.82, 31.24, 30.35, 30.16, 30.13, 29.97, 29.80, 29.50, 27.83,
27.55, 27.39, 26.94, 26.74 ppm; IR (KBr) 3430, 3310, 2927, 2854,
1698, 1633, 1558, 1471, 1458, 1261, 1149, 1054, 1037 cm−1; HRMS
(FAB) calcd for C29H53N8O3S [M + H]+ 593.3961; found 593.3962.
General Procedure for Affinity Labeling of Avidin. Avidin
(0.75 nmol) in a phosphate buffer (10 μL, 50 mM, pH 8.0) and ligand
catalyst (3.0 nmol) in a phosphate buffer (5 μL, 50 mM, pH 8.0) were
mixed in a microtube and left to stand at rt for 30 min. To this
solution, Cascade Blue ethylenediamine (60 nmol) in a phosphate
buffer (20 μL, 50 mM, pH 8.0), CDMT (60 nmol) in a mixture
(10 μL) of a phosphate buffer (50 mM, pH 8.0) and MeOH (5% v/v),
and a phosphate buffer (30 μL, 50 mM, pH 8.0) were added. The re-
sulting solution was shaken using a vortex mixer. The final concentration
of each component in the reaction mixture was as follows: avidin, 10 μM;
ligand catalyst, 40 μM; Cascade Blue ethylenediamine, 800 μM; CDMT,
800 μM. The reaction mixture was then left to stand at rt for 24 h. It was
then subjected to gel chromatography at rt (support: Sephadex G-50
medium; column size: 350 × 7 mm; elution: 50 mM phosphate buffer at
pH 8.0), and avidin-containing fractions were collected. The yields of
labeling of avidin were determined by UV absorption spectra of the
collected fractions.10,11
the “BEST” software program.30 The KW (equivalent to aH aOH ), KW
+
−
́
(equivalent to [H+][OH−]), and f H values used at 25 °C were
+
10−14.00, 10−13.79, and 0.825, respectively. The corresponding mixed
−
+
constants K2 (= [HO -bound species]aH /[H2O-bound species]),
+
+
+
were derived using [H ] = aH /f H
.
General Procedure for the Amide-Forming Reaction. To a
stirred solution of 3-phenylpropionic acid (38 mg, 0.25 mmol),
benzylamine (30 μL, 0.28 mmol), and tert-amine 1 (0.30 mmol) in
MeOH (1.0 mL) was added a MeOH solution of CDMT (48 mg,
0.28 mmol) at rt. After stirring at rt, the reaction mixture was
quenched with 1 M aqueous solution of KHSO4 (3 mL) and was then
concentrated under reduced pressure. The residue was extracted with
Et2O, and the organic phase was washed sequentially with water, 1 M
aqueous HCl, water, 1 M aqueous NaOH, water, saturated aqueous
NaHCO3, and brine. The extract was dried over MgSO4, filtrated, and
concentrated under reduced pressure. The yields of 6a and 6b7 were
determined using 1H NMR measurements of the crude product, which
contained imidazole or (E)-N,N-dimethylcinnamamide as an internal
standard.
In the case of entry 2 in Table 1, an unstable imidate ester 12, which
could be analyzed only by 1H NMR and mass spectroscopy, was
obtained (13.7 mg, 15% yield based on CDMT). 1H NMR (400 MHz,
CDCl3/TMS) δ 7.37−7.19 (m, 5H), 5.29 (s, 2H), 3.99 (s, 6H), 3.91
(s, 2H), 2.29 (s, 6H) ppm; LRMS (ESI-hexapole) m/z 332 [M + H]+.
N-(17-Azido-3,6,9,12,15-pentaoxaheptadecyl)biotinamide (13).
To a solution of 17-azido-3,6,9,12,15-pentaoxa-1-heptadecylamine31
(180 mg, 0.588 mmol) and (+)-biotin (144 mg, 0.588 mmol) in
MeOH (5 mL) was added DMT-MM4−7 (244 mg, 0.881 mmol) at rt.
After stirring overnight at rt, the solvent was removed under vacuum.
The crude mixture was purified by silica gel column chromatography
(CHCl3/MeOH = 9:1) to give the desired compound as colorless
1
crystals (179 mg, 57% yield). mp 96−97 °C. H NMR (400 MHz,
methanol-d4/TMS) δ 8.03 (s, 1H), 4.49 (dd, J = 7.8, 4.6 Hz, 1H), 4.30
(dd, J = 7.8, 4.6 Hz, 1H), 3.81−3.64 (m, 18H), 3.54 (t, J = 4.8 Hz,
2H), 3.37−3.30 (brs, 4H), 3.23−3.18 (m, 1H), 2.93 (dd, J = 12.6, 4.8
Hz, 1H), 2.70 (d, J = 12.8 Hz, 1H), 2.22 (t, J = 7.1 Hz, 2H), 1.76−1.61
(m, 4H), 1.48−1.40 (m, 2H) ppm; 13C NMR (100 MHz, methanol-
d4) δ 176.08, 166.06, 71.62, 71.55, 71.51, 71.23, 71.13, 70.56, 63.33,
61.59, 57.00, 51.76, 41.05, 40.34, 36.71, 29.77, 29.49, 26.84 ppm; IR
(CHCl3) 2931, 2102, 1702, 1648, 1452, 1107 cm−1; LRMS (ESI-
hexapole) 533 [M + H]+; HRMS (ESI-TOF) m/z [M + Na]+ Calcd
for C22H40N6NaO7S 555.2577; found 555.2554.
ASSOCIATED CONTENT
* Supporting Information
Potentiometric pH titration experiments for 1 (Figures S1 and
■
S
Ligand Catalyst (7a). To a solution of 13 (80 mg, 0.15 mmol),
N,N-dimethylpropargylamine (19 mg, 0.23 mmol), and sodium
ascorbate (3.0 mg, 0.015 mmol) in t-BuOH/H2O (2:1, 2 mL) was
added CuSO4·5H2O (1.9 mg, 0.0076 mmol) at rt. After stirring for
20 h at rt, the solvent was removed under vacuum. The crude mixture
was purified by silica gel column chromatography (CHCl3/MeOH =
85:15 containing 1% Et3N) to give 65 mg of the desired compound as
S2, Table S1, and Scheme S1); Schemes S2 and S3; Tables S2
1
and S3; and H and 13C NMR spectra for 1a−1h, 7a, 7b, 13,
and 14. This material is available free of charge via the Internet
AUTHOR INFORMATION
Corresponding Author
■
1
colorless crystals (71% yield). mp 116−117 °C. H NMR (400 MHz,
CDCl3/TMS) δ 7.70 (s, 1H), 6.89 (brs, 1H), 6.29 (brs, 1H), 5.39 (brs,
1H), 4.55 (t, J = 5.3 Hz, 2H), 4.51 (dd, J = 7.1, 4.8 Hz, 1H), 4.32 (dd,
J = 7.1, 4.4 Hz, 1H), 3.88 (t, J = 5.0 Hz, 2H), 3.63 (t, J = 5.0 Hz, 18H),
3.56 (t, J = 5.0 Hz, 2H), 3.46−3.41 (m, 2H), 3.15 (dd, J = 11.9, 7.3 Hz,
1H), 2.91 (dd, J = 12.8, 5.0 Hz, 1H), 2.74 (d, J = 12.8 Hz, 1H), 2.29 (s,
6H), 2.23 (t, J = 7.3 Hz, 2H), 1.80−1.61 (m, 4H), 1.48−1.40 (m, 2H)
ppm; 13C NMR (100 MHz, CDCl3) δ 173.32, 163.93, 144.63, 123.79,
70.55, 70.53, 70.51, 70.46, 70.44, 70.38, 70.07, 69.96, 69.54, 61.75,
60.16, 55.59, 54.26, 50.21, 45.03, 40.55, 39.14, 35.92, 28.19, 28.10,
25.60 ppm; IR (CHCl3) 2931, 1701, 1658, 1458, 1103 cm−1; LRMS
(ESI-hexapole) 616 [M + H]+; HRMS (FAB) calcd for C27H50N7O7S
[M + H]+ 616.3492; found 616.3495.
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
This work was supported by JSPS KAKENHI Grant (Nos.
23590004 and 25460013).
■
REFERENCES
■
(1) Montalbetti, C. A. G. N.; Falque, V. Tetrahedron 2005, 61,
10827−10852.
(2) El-Faham, A.; Albericio, F. Chem. Rev. 2011, 111, 6557−6602.
N-[5-(8-Azidooct-1-ylaminocarbonyl)pent-1-yl]biotinamide (14).
This compound was synthesized from 6-(biotinylamino)hexanoic acid
3713
dx.doi.org/10.1021/jo500376m | J. Org. Chem. 2014, 79, 3709−3714